I am a
Home I AM A Search Login

Papers of the Week

Papers: 14 Jan 2023 - 20 Jan 2023

Pharmacology/Drug Development

2023 Jan 18


Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.


Ashina M, Tepper SJ, Reuter U, Blumenfeld AM, Hutchinson S, Xia J, Miceli R, Severt L, Finnegan M, Trugman JM
Headache. 2023 Jan 18.
PMID: 36651532.


To assess long-term safety, tolerability, and efficacy of once-daily oral atogepant 60 mg in adults with migraine.